Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence

Kidney Blood Press Res. 2022;47(10):593-596. doi: 10.1159/000526791. Epub 2022 Sep 5.
No abstract available

Keywords: Angiotensin II; Bartter’s syndrome; COVID-19; Gitelman’s syndrome; RAS blockers.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II
  • Bartter Syndrome*
  • COVID-19*
  • Humans

Substances

  • Angiotensin II

Grants and funding

This study was supported in part by the University of Padova, grant number DOR 2084023/2020 to Lorenzo A Calò.